elf Beauty Inc
ELF
$81.40 -0.27%
Exchange: NYSE | Sector: Consumer Defensive | Industry: Household Personal Products
Q4 2024
Published: May 23, 2024

Earnings Highlights

  • Revenue of $321.14M up 71.4% year-over-year
  • EPS of $0.25 decreased by 16.1% from previous year
  • Gross margin of 70.7%
  • Net income of 14.53M
  • "In fiscal '24, we grew net sales by 77%, increased gross margin by approximately 330 basis points, grew adjusted EBITDA by 101% and increased market share of 305 basis points, well above our original expectations." - Tarang Amin
ELF
Company ELF

Executive Summary

Executive summary: elf Beauty delivered a landmark quarter and a strong fiscal year. In Q4'24, net sales rose 71% year-over-year to $321.1 million, contributing to a full-year net sales increase of 77% and the achievement of over $1 billion in annual net sales. Gross margin expanded roughly 180 basis points in Q4 and approximately 330 basis points for FY'24, while adjusted EBITDA surged about 93% in the quarter and 101% for the full year, underscoring the company’s ability to translate top-line momentum into profitability. Management credited three enduring pillarsβ€”value proposition, product innovation, and a disruptive marketing engineβ€”as the engine of category-leading growth. International growth accelerated meaningfully (Q4 international net sales up 115%), and Naturium, acquired in October, contributed meaningfully to net sales in Q4 and is central to near-term and longer-term growth plans.

Execution remains differentiated by a highly efficient go-to-market, rapid market-share gains in color cosmetics and skin care, and a meaningful expansion in international penetration. Despite macro uncertainty and some cost headwinds (notably transportation and FX effects in FY'25 planning), management outlined a disciplined, quarter-by-quarter approach to the FY'25 outlook with a 20–22% net sales growth target and modest gross-margin expansion (roughly +10 bps year-over-year). The company signaled continued aggressive investment in marketing and digital channels (roughly 24–26% of net sales in FY'25) to sustain the flywheel. Investors should monitor: 1) Naturium integration and Ulta launch execution; 2) international rollout cadence and space gains at CVS, Walmart, and Sephora Mexico; 3) evolving freight, FX, and retailer activity costs that influence near-term gross margins; and 4) the path to continued EBITDA margin expansion as top-line momentum converts into operating leverage.

Key Performance Indicators

Revenue
Increasing
321.14M
QoQ: 18.53% | YoY: 71.41%
Gross Profit
Increasing
227.20M
70.75% margin
QoQ: 18.36% | YoY: 75.95%
Operating Income
Increasing
17.03M
QoQ: -46.51% | YoY: 111.68%
Net Income
Decreasing
14.53M
QoQ: -45.97% | YoY: -10.58%
EPS
Decreasing
0.26
QoQ: -46.94% | YoY: -16.13%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2026 353.74 0.58 +10.2% View
Q3 2025 355.32 0.60 +31.1% View
Q2 2025 301.08 0.33 +39.7% View
Q1 2025 324.48 0.81 +50.0% View
Q4 2024 321.14 0.25 +71.4% View